TSND Share Price Performance
CA$0.99
0.63 (171.23%)
50.5% undervalued intrinsic discount
CA$2.00
Fair Value
Price CA$0.99
AnalystHighTarget CA$2.00
AnalystLowTarget CA$1.27
AnalystConsensusTarget CA$1.86
Fair ValueCA$2.00
Share Pricen/a
TerrAscend Corp. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
TSND Community Narratives
AN
Fair Value CA$2 50.5% undervalued intrinsic discount
US Cannabis Legalization And Digital Health Will Unlock Opportunities
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value CA$1.27 21.8% undervalued intrinsic discount
North American Cannabis Will Face Oversupply And Risks Yet Recover
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value CA$1.88 47.2% undervalued intrinsic discount
Expanding Adult-Use And Medical Cannabis Markets Will Redefine The Industry
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
North American Cannabis Will Face Oversupply And Risks Yet Recover
Key Takeaways Dependence on regulatory progress and geographic concentration makes growth and margins vulnerable to shifting laws, competition, and price compression in key U.S. markets. Industry oversupply, persistent stigma, and potential new competitors could limit sales momentum, erode margins, and challenge long-term earnings resilience.Read more
10
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
CA$1.27
21.8% undervalued intrinsic discount
Fair Value
Profit Margin
7.72%
Future PE
17.76x
Price in 2029
CA$1.52
US Cannabis Legalization And Digital Health Will Unlock Opportunities
Key Takeaways Expansion into new states, operational efficiencies, and premium branding position TerrAscend for strong revenue growth and improved margins versus industry peers. Strategic M&A, digital platform expansion, and disciplined cost control create potential for sustainable earnings growth and increased market share as the sector consolidates.Read more
43
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
CA$2
50.5% undervalued intrinsic discount
Fair Value
Profit Margin
3.81%
Future PE
56.67x
Price in 2029
CA$2.4
Expanding Adult-Use And Medical Cannabis Markets Will Redefine The Industry
Key Takeaways Expansion into newly legalized states and premium product offerings position the company for sustained revenue growth and improved profitability as markets broaden. Vertical integration, strategic M&A, and digital-first initiatives enhance cost efficiency, operating margins, and reduce risk through focus on high-growth, regulated markets.Read more
20
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
CA$1.88
47.2% undervalued intrinsic discount
Fair Value
Profit Margin
1.2%
Future PE
184.55x
Price in 2028
CA$2.72
Trending Discussion
Recently Updated Narratives
AN
TSND: New CFO Hire And Share Buyback Will Support Future Upside
Fair Value: CA$1.27 21.8% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
TSND: Expanded New Jersey Retail Footprint Will Support Future Profitability
Fair Value: CA$2 50.5% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Expanding Adult-Use And Medical Cannabis Markets Will Redefine The Industry
Fair Value: CA$1.88 47.2% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
TerrAscend Corp. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -0.096
- 52.32%
- -11.28%
- 228.7%
About TSND
- Founded
- 2017
- Employees
- 933
- CEO
- WebsiteView website
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, and Cookies. The company also operates retail dispensaries under the Apothecarium brand name. It serves medical patients and adult-use consumers in North America. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.
